1. |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018, 68(6): 394-424.
|
2. |
中华人民共和国国家卫生健康委员会. 胰腺癌诊疗规范(2018年版). 临床肝胆病杂志, 2019, 35(2): 281-293.
|
3. |
Nakano Y, Kitago M, Shinoda M, et al. Clinical predictive factors of long-term survival after curative resection of pancreatic cancer: a retrospective study. Cancer Med, 2017, 6(10): 2278-2286.
|
4. |
Nathan H, Yin H, Wong SL. Postoperative complications and long-term survival after complex cancer resection. Ann Surg Oncol, 2017, 24(3): 638-644.
|
5. |
Li J, Li Z, Kan H, et al. CA19-9 elevation as an indication to start salvage treatment in surveillance after pancreatic cancer resection. Pancreatology, 2019, 19(2): 302-306.
|
6. |
Luo G, Fan Z, Cheng H, et al. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer. Pancreatology, 2018, 18(8): 971-976.
|
7. |
Martin HL, Ohara K, Kiberu A, et al. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer. Intern Med J, 2014, 44(7): 676-682.
|
8. |
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet, 2001, 357(9255): 539-545.
|
9. |
Coussens LM, Werb Z. Inflammation and cancer. Nature, 2002, 420(6917): 860-867.
|
10. |
Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature, 2008, 454(7203): 436-444.
|
11. |
Sideras K, Braat H, Kwekkeboom J, et al. Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies. Cancer Treat Rev, 2014, 40(4): 513-522.
|
12. |
Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 2014, 106(6): dju124.
|
13. |
Gorgel SN, Ozer K, Kose O, et al. Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass? Int Braz J Urol, 2018, 44(3): 461-466.
|
14. |
Wang Y, Peng C, Cheng Z, et al. The prognostic significance of preoperative neutrophil-lymphocyte ratio in patients with hepatocellular carcinoma receiving hepatectomy: A systematic review and meta-analysis. Int J Surg, 2018, 55: 73-80.
|
15. |
Miyamoto R, Inagawa S, Sano N, et al. The neutrophil-to-lymphocyte ratio (NLR) predicts short-term and long-term outcomes in gastric cancer patients. Eur J Surg Oncol, 2018, 44(5): 607-612.
|
16. |
Rashtak S, Ruan X, Druliner BR, et al. Peripheral neutrophil to lymphocyte ratio improves prognostication in colon cancer. Clin Colorectal Cancer, 2017, 16(2): 115-123.
|
17. |
李晓明, 向宗骏, 万志渝, 等. 外周血炎性指标比值对中晚期食管鳞癌术后复发的预测价值. 中国胸心血管外科临床杂志, 2019, 26(9): 865-869.
|
18. |
Melstrom LG, Salazar MD, Diamond DJ. The pancreatic cancer microenvironment: A true double agent. J Surg Oncol, 2017, 116(1): 7-15.
|
19. |
Thompson PA, Khatami M, Baglole CJ, et al. Environmental immune disruptors, inflammation and cancer risk. Carcinogenesis, 2015, Suppl 1(Suppl 1): S232-S253.
|
20. |
Laird BJ, McMillan DC, Fayers P, et al. The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist, 2013, 18(9): 1050-1055.
|
21. |
Sionov RV, Fridlender ZG, Granot Z. The multifaceted roles neutrophils play in the tumor microenvironment. Cancer Microenviron, 2015, 8(3): 125-158.
|
22. |
Tazzyman S, Niaz H, Murdoch C. Neutrophil-mediated tumour angiogenesis: subversion of immune responses to promote tumour growth. Semin Cancer Biol, 2013, 23(3): 149-158.
|
23. |
Bergers G, Benjamin LE. Tumorigenesis and the angiogenic switch. Nat Rev Cancer, 2003, 3(6): 401-410.
|
24. |
Tazzyman S, Lewis CE, Murdoch C. Neutrophils: key mediators of tumour angiogenesis. Int J Exp Pathol, 2009, 90(3): 222-231.
|
25. |
Ray-Coquard I, Cropet C, Van Glabbeke M, et al. Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res, 2009, 69(13): 5383-5391.
|
26. |
Berntsson J, Nodin B, Eberhard J, et al. Prognostic impact of tumour-infiltrating B cells and plasma cells in colorectal cancer. Int J Cancer, 2016, 139(5): 1129-1139.
|
27. |
Gooden MJ, de Bock GH, Leffers N, et al. The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer, 2011, 105(1): 93-103.
|
28. |
Tachibana T, Onodera H, Tsuruyama T, et al. Increased intratumor Ⅴα24-positive natural killer T cells: a prognostic factor for primary colorectal carcinomas. Clin Cancer Res, 2005, 11(20): 7322-7327.
|
29. |
Tang Y, Xu X, Guo S, et al. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma. PLoS One, 2014, 9(3): e91551.
|